Armata Pharmaceuticals (ARMP) Convertible Debt (2023 - 2026)
Quarterly results put Convertible Debt at $254.9 million for Q1 2026, changed N/A from a year ago — trailing twelve months through Mar 2026 was $254.9 million (changed N/A YoY), and the annual figure for FY2025 was $153.9 million, up 367.7%.
Armata Pharmaceuticals has reported Convertible Debt over the past 4 years, most recently at $254.9 million for Q1 2026.
- Convertible Debt reached $254.9 million in Q1 2026 per ARMP's latest filing, up from $153.9 million in the prior quarter.
- Across five years, Convertible Debt topped out at $254.9 million in Q1 2026 and bottomed at $30.0 million in Q3 2024.
- Median Convertible Debt over the past 4 years was $41.3 million (2023), compared with a mean of $80.0 million.
- The largest annual shift saw Convertible Debt plummeted 43.89% in 2024 before it soared 367.7% in 2025.
- Over 4 years, Convertible Debt stood at $58.6 million in 2023, then plummeted by 43.89% to $32.9 million in 2024, then skyrocketed by 367.7% to $153.9 million in 2025, then soared by 65.68% to $254.9 million in 2026.
- Business Quant data shows Convertible Debt for ARMP at $254.9 million in Q1 2026, $153.9 million in Q4 2025, and $30.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 254.92 Mn |
| Dec 31, 2025 | 153.86 Mn |
| Sep 30, 2025 | 30.00 Mn |
| Jun 30, 2025 | 30.00 Mn |
| Dec 31, 2024 | 32.90 Mn |
| Sep 30, 2024 | 30.00 Mn |
| Dec 31, 2023 | 58.63 Mn |
| Sep 30, 2023 | 49.75 Mn |